CERULEAN PHARMA INC's ticker is CERU and the CUSIP is 15708Q105. A total of 37 filers reported holding CERULEAN PHARMA INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $1,000 | 0.0% | 1,809 | 0.0% | 0.00% | – |
Q1 2017 | $1,000 | 0.0% | 1,809 | +0.5% | 0.00% | – |
Q4 2016 | $1,000 | -66.7% | 1,800 | -45.5% | 0.00% | – |
Q3 2016 | $3,000 | -72.7% | 3,300 | -37.7% | 0.00% | – |
Q2 2016 | $11,000 | -15.4% | 5,300 | +10.4% | 0.00% | – |
Q1 2016 | $13,000 | 0.0% | 4,800 | 0.0% | 0.00% | – |
Q4 2015 | $13,000 | -27.8% | 4,800 | 0.0% | 0.00% | – |
Q3 2015 | $18,000 | -18.2% | 4,800 | 0.0% | 0.00% | – |
Q2 2015 | $22,000 | -15.4% | 4,800 | +68.4% | 0.00% | – |
Q1 2015 | $26,000 | +333.3% | 2,850 | +185.0% | 0.00% | – |
Q4 2014 | $6,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co. V, L.L.C. | 3,287,529 | $8,909,000 | 8.51% |
Polaris Venture Management Co IV LLC | 1,437,441 | $3,895,000 | 7.33% |
Rock Springs Capital Management LP | 625,000 | $1,694,000 | 0.14% |
Deer VII & Co. Ltd. | 166,675 | $452,000 | 0.12% |
Granahan Investment Management | 730,015 | $1,978,000 | 0.07% |
Northeast Financial Consultants Inc | 20,000 | $54,000 | 0.03% |
Donald L. Hagan, LLC | 3,900 | $11,000 | 0.01% |
Alyeska Investment Group, L.P. | 312,809 | $848,000 | 0.01% |
WEDBUSH SECURITIES INC | 16,000 | $43,000 | 0.01% |
TFS CAPITAL LLC | 15,895 | $43,000 | 0.01% |